SNRPCP16

Across TCGA pan-cancer cohorts, SNRPCP16 RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated SNRPCP16 data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher SNRPCP16 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated SNRPCP16 expression acts as an unfavorable survival marker, although some lineages such as BRCA and LAML show a favorable association.

STAD, BRCA, and LAML are the cancer types where SNRPCP16 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Median	All	0.265	0.545	<.001	63	view →
BRCA	OS	Median	III,IV	0.904	0.760	<.001	58	view →
LAML	DFS	Median	All	0.682	0.453	.001	42	view →
SKCM	OS	Tertile	II,III,IV	0.922	0.809	.021	13	view →
CESC	OS	Tertile	II,III,IV	0.726	0.444	.030	10	view →
ACC	DFS	Tertile	IV	0.656	0.120	.009	9	view →
COAD	OS	Median	II,III,IV	0.485	0.615	.015	8	view →
THYM	DFS	Quartile	II,III,IV	0.570	0.956	.014	7	view →
HNSC	OS	Tertile	All	0.484	0.633	.043	6	view →
CHOL	DFS	Quartile	III,IV	1.000	0.174	.040	3	view →
KIRC	OS	Quartile	All	0.862	0.788	.026	3	view →
UVM	DFS	Tertile	All	0.746	0.476	.045	2	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 18 lineages.

SNRPCP16–STAD (OS)

Open the STAD breakdown →